1-(4-methyl-quinine-2-il) methyl-3-methyl-7-(2-Butin-1-il) -8-(3-(R) -amino-Piperidin-1-il) -Xantina, DPP-4 inhibitors, are used to treat and/or prevent metabolic diseases in patients who cannot be treated with methylfen and/or renal failure.

摘要

Use of Derivatives of purine Compounds, inhibitors of DPP for treat and / or prevent Metabolic Diseases in patients who cannot be treated with Metformin.